NextCure ownership: ADAR1 reports 375,658 shares

NextCure, Inc. insider ownership is reported by private investment funds managed by ADAR1 Capital Management, LLC and by Daniel Schneeberger, who together indirectly hold 375,658 shares of NextCure common stock.

Accepted by SEC EDGAR 07/29/2026 - 06:04 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

NextCure, Inc. insider ownership is reported by private investment funds managed by ADAR1 Capital Management, LLC and by Daniel Schneeberger, who together indirectly hold 375,658 shares of NextCure common stock.

The shares are held by the funds, and each reporting person disclaims beneficial ownership beyond his or its pecuniary interest for Section 16 purposes.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider ADAR1 Capital Management, LLC, Schneeberger Daniel

Role 10% Owner | 10% Owner

Type	Security	Shares	Price	Value
Holding	Common Stock F1, F2	--	--	--

Holdings: Common Stock — 375,658 shares (Indirect, See Footnote)

Footnotes (2)

1. F1. The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.
2. F2. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

Key Figures

Indirectly held common shares: 375,658 shares Holding entries reported: 1 Buy transactions in this report: 0

3 metrics

Indirectly held common shares 375,658 shares Common Stock indirectly owned through private investment funds managed by ADAR1 Capital Management, LLC

Holding entries reported 1 Number of Common Stock holding entries listed for the reporting persons

Buy transactions in this report 0 BuyCount recorded in the transaction summary for this insider report

Key Terms

beneficial ownership, pecuniary interest, Section 16 of the Securities Exchange Act of 1934

3 terms

beneficial ownership regulatory

"each Reporting Person disclaims beneficial ownership of any such securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest regulatory

"except to the extent of his/its pecuniary interest therein, if any"

Section 16 of the Securities Exchange Act of 1934 regulatory

"For purposes of Section 16 of the Securities Exchange Act of 1934, as amended"

A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NextCure (NXTC) shares are indirectly held by ADAR1-managed funds?

ADAR1-managed funds indirectly hold 375,658 shares of NextCure common stock. These shares are reported as being owned by private investment funds managed by ADAR1 Capital Management, LLC, with indirect beneficial ownership potentially attributed to ADAR1 and Daniel Schneeberger.

Who are the reporting persons in the NextCure (NXTC) insider ownership report?

The reporting persons are ADAR1 Capital Management, LLC and Daniel Schneeberger. ADAR1 manages the private investment funds that directly own the NextCure shares, and Schneeberger is the sole manager of ADAR1, giving him potential indirect beneficial ownership for Section 16 purposes.

What type of security is reported for NextCure (NXTC) by ADAR1 and Daniel Schneeberger?

The security reported is Common Stock of NextCure, Inc. A single holding entry shows 375,658 shares of common stock indirectly owned through private investment funds managed by ADAR1 Capital Management, LLC, rather than directly by the individual reporting person.

How do the reporting persons treat beneficial ownership of NXTC shares?

Each reporting person disclaims beneficial ownership of the reported NXTC shares except to the extent of his or its pecuniary interest. This means they do not concede full beneficial ownership for Section 16 or other purposes beyond their economic stake, if any.

Are the reported NXTC shares held directly by ADAR1 and Daniel Schneeberger?

No. The 375,658 shares of NXTC common stock are owned directly by private investment funds managed by ADAR1. The filing notes that ADAR1 and Daniel Schneeberger may be deemed to indirectly beneficially own these securities through their roles with the funds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ADAR1 Capital Management, LLC

(Last) (First) (Middle)

3503 WILD CHERRY DRIVE

BUILDING 9

(Street)

AUSTIN TEXAS 78738

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/27/2026

3. Issuer Name and Ticker or Trading Symbol
NextCure, Inc. [ NXTC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	375,658	I	See Footnote(1)(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

ADAR1 Capital Management, LLC

(Last) (First) (Middle)

3503 WILD CHERRY DRIVE

BUILDING 9

(Street)

AUSTIN TEXAS 78738

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Schneeberger Daniel

(Last) (First) (Middle)

3503 WILD CHERRY DRIVE

BUILDING 9

(Street)

AUSTIN TEXAS 78738

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.

2. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

	ADAR1 Capital Management, LLC By: Daniel Schneeberger, Manager /s/ Daniel Schneeberger	07/29/2026
	/s/ Daniel Schneeberger	07/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)